Pharmaguy's Insights Into Drug Industry News
183.5K views | +20 today
Follow
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

Does pharma need a "chief patient officer"? Hell Yeah!

Does pharma need a "chief patient officer"? Hell Yeah! | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Adding a chief patient officer, alone, is not going to change the culture of pharma from “what’s the ROI?” to “how can we make a difference in patients’ lives?”


A Chief Patient Officer, on paper, sound like a good idea, but what pharma really needs is more people who have empathy and less people who want presentations and spreadsheets.  The culture within most pharma companies is one of “ROI first, patients second”.  Years of layoffs have led to a void of talent and while there are still some good people left within the industry too many have marketers have exited.

Pharma Guy's insight:


Rich Meyer may not have listened to my podcast interview of Sanofi's Anne Beal, the first Chief Privacy Officer of a major pharmaceutical company. Dr. Beal's main role is to be a change manager throughout the organization. The fact that's she in a C-suite position means that she lauds it over mere Directors that Rich complains about. Listen to the podcast here: http://bit.ly/PMT232

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

23andMe and "e-Patient Davide": the Rise of the Chief Patient Kibitzer!

23andMe and "e-Patient Davide": the Rise of the Chief Patient Kibitzer! | Pharmaguy's Insights Into Drug Industry News | Scoop.it

MOUNTAIN VIEW, Calif., – April 1 2015 – 23andMe today announced the appointment of Davide deBellagio, also known as “e-Patient Davide,” to the newly created position of Chief Patient Officer.

“The appointment of a Chief Patient Officer at 23andMe, the first for a Silicon Valley pharmaceutical company, shows our commitment to go further than mainstream pharma1 in meeting the needs of patients and our investors,” said Steve Woz, an unspecified 23and Me executive“Interactions with patients are a source of strength -- and wealth -- for the company and e-Patient Davide’s appointment will help ensure the patient perspective advances our profits and our approach to meeting the unmet needs of our investors, which include Roche and Johnson & Johnson.”

e-Patient Davide -- a pre-Alzheimer’s survivor -- is an international keynote speaker on healthcare who consistently earns extraordinary fees from consulting with various healthcare organizations.

I am incredibly honored to be 23andMe's first Chief Patient Officer, or as I like to call it, Chief Patient Kibitzer,” said e-Patient Davide. The Internet has altered the balance of power in healthcare. Patients are managing their own health and, in partnership with the pharmaceutical industry, making some money to boot.

Pharma Guy's insight:


Happy April Fools' Day! Although I would like to see pharma hire REAL patient advocates as Chief Patient Officers rather than medical professionals. With the latter it just sounds like a new name for Chief Medical Officer, although Dr. Anne Beal - Chief Patient Officer at Sanofi - explained how the two differ. Listen to my interview of her here: http://bit.ly/PMT232

more...
No comment yet.